BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
Not yet recruiting · NCT06645301 · Registry updated 2024-10-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder | Not yet recruiting | Early phase 1 | 2024-10-16 | NCT06645301 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioSyngen Pte Ltd | 5 |
| South China Hospital of Shenzhen University | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||